Advertisement
Advertisement
KMDA
Kamada Ltd
7.76
USDSponsored
-0.67
-7.89%
May 13, 10:27 UTC -4
Open
KMDA Earnings Reports
Positive Surprise Ratio
KMDA beat 24 of 41 last estimates.
59%
Next Report
Date of Next Report
Aug 11, 2026
Estimate for Q2 26 (Revenue/ EPS)
$50.85M
/$0.12
Implied change from Q1 26 (Revenue/ EPS)
+12.39%
/+71.43%
Implied change from Q2 25 (Revenue/ EPS)
+13.61%
/-7.69%
Kamada Ltd earnings per share and revenue
On May 13, 2026, KMDA reported earnings of 0.07 USD per share (EPS) for Q1 26, missing the estimate of 0.11 USD, resulting in a -40.32% surprise. Revenue reached 45.24 million, compared to an expected 47.66 million, with a -5.07% difference.
Looking ahead to Q2 26, 4 analysts forecast an EPS of 0.12 USD, with revenue projected to reach 50.85 million USD, implying an increase of 71.43% EPS, and increase of 12.39% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Vor Biopharma Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.78
Actual
-$0.73
Surprise
+7.38%
Abeona Therapeutics Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.36
Actual
-$0.30
Surprise
+17.31%
Milestone Pharmaceuticals Inc. Common Shares
Report Date
May 13, 2026 For Q1 26
Estimate
$0.31
Actual
-$0.20
Surprise
-163.94%
Protalix BioTherapeutics, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.01
Actual
$0.22
Surprise
+2278.22%
Immunic, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.93
Actual
-$1.08
Surprise
-16.03%
Humacyte, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.11
Actual
-$0.09
Surprise
+24.05%
Spruce Biosciences, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$8.99
Actual
-$8.94
Surprise
+0.58%
BeyondSpring Inc. Ordinary Shares
Report Date
May 13, 2026 For Q1 26
Estimate
-Actual
-$0.05
Surprise
-
PDS Biotechnology Corporation Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.15
Actual
-$0.13
Surprise
+15.03%
Aprea Therapeutics, Inc. Common stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.23
Actual
-$0.22
Surprise
+6.22%
FAQ
What were Kamada Ltd's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Kamada Ltd reported EPS of $0.07, missing estimates by -40.32%, and revenue of $45.24M, -5.07% below expectations.
How did the market react to Kamada Ltd's Q1 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Kamada Ltd expected to report next?
The next earning report is scheduled for Aug 11, 2026.
What are the forecasts for Kamada Ltd's next earnings report?
Based on 4
analysts, Kamada Ltd is expected to report EPS of $0.12 and revenue of $50.85M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement